Oncoscience AG

πŸ‡¨πŸ‡­Switzerland
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.oncoscienceag.com

Nimotuzumab in Adults With Glioblastoma Multiforma

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-09-16
Last Posted Date
2012-12-03
Lead Sponsor
Oncoscience AG
Target Recruit Count
150
Registration Number
NCT00753246
Locations
πŸ‡©πŸ‡ͺ

Dep. Neurosurgery, Univ. Hamburg, Hamburg, Germany

Nimotuzumab in Children With Intrinsic Pontine Glioma

First Posted Date
2007-11-21
Last Posted Date
2013-03-29
Lead Sponsor
Oncoscience AG
Target Recruit Count
41
Registration Number
NCT00561691
Locations
πŸ‡©πŸ‡ͺ

University Bonn, Children's Medical Hospital, Bonn, Germany

Nimotuzumab in Children With HGG

Completed
Conditions
First Posted Date
2007-11-21
Last Posted Date
2007-11-21
Lead Sponsor
Oncoscience AG
Target Recruit Count
45
Registration Number
NCT00561873
Locations
πŸ‡©πŸ‡ͺ

University Bonn, Children's Medical Hospital, Bonn, Germany

Nimotuzumab in Adults With Pancreatic Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-11-21
Last Posted Date
2015-10-15
Lead Sponsor
Oncoscience AG
Target Recruit Count
188
Registration Number
NCT00561990
Locations
πŸ‡©πŸ‡ͺ

Marienhospital Herne, Herne, Germany

Β© Copyright 2024. All Rights Reserved by MedPath